In vitro minocycline activity on superinfecting microorganisms isolated from chronic periodontitis patients

Brazilian Oral Research
|November 23, 2006
PubMed

Insights

Minocycline effectively inhibits common periodontal pathogens like Staphylococcus and Enterobacteriaceae at low concentrations. However, higher concentrations are needed for Candida and Pseudomonas aeruginosa, with some strains remaining resistant even at 1,000 microg/mL.

Area of Science:

  • Microbiology
  • Periodontology
  • Pharmacology

Background:

  • Chronic periodontitis involves diverse microorganisms, including enteric rods, Pseudomonas, Staphylococcus, and Candida, often leading to superinfections.
  • Antibiotic therapy, particularly minocycline, is considered for managing periodontal pathogens alongside mechanical treatments.

Purpose of the Study:

  • To determine the minimal inhibitory concentration (MIC) of minocycline against microorganisms commonly found in chronic periodontitis superinfections.
  • To assess minocycline's efficacy against Enterobacteriaceae, Staphylococcus spp., Pseudomonas aeruginosa, and Candida spp. isolated from periodontal pockets.

Main Methods:

  • The study utilized the Müeller-Hinton agar dilution method to determine MIC values.
  • Microorganisms tested included 25 Enterobacteriaceae, 25 Staphylococcus spp., 9 Pseudomonas aeruginosa, and 25 Candida spp. isolates.

Main Results:

  • Staphylococcus spp. showed the highest sensitivity to minocycline (MIC = 8 microg/mL).
  • Enterobacteriaceae were inhibited at 16 microg/mL, and 96% of Candida spp. were inhibited at the same concentration.
  • Pseudomonas aeruginosa exhibited higher resistance, with 88.8% inhibited at 128 microg/mL, and 1,000 microg/mL failed to inhibit all isolates.

Conclusions:

  • Minocycline demonstrates variable efficacy against different microbial species associated with chronic periodontitis.
  • Effective treatment of superinfections may require tailored antibiotic strategies due to observed resistance patterns, especially in Pseudomonas aeruginosa and Candida spp.